E

Enanta Pharmaceuticals
D

ENTA

8.84000
USD
0.28
(3.27%)
مغلق
حجم التداول
3,532
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
187,306,968
أصول ذات صلة
    A
    ALX
    0.900
    (0.42%)
    217.400 USD
    A
    APLS
    -1.750
    (-6.24%)
    26.280 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    M
    MCRB
    -0.04240
    (-7.16%)
    0.54970 USD
    المزيد
الأخبار

العنوان: Enanta Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.